Console: Russian Cardioplegic Remedy
Consol is one of the pharmaceutical products produced in Russia by Samson-Med. It belongs to the pharmaceutical group of cardioplegic drugs, which are used in cardiac surgery to stop the heart and ensure safety during open-heart surgery.
The drug Consol is produced by several companies, including Biopharm-94 and Samson-Med. It has the international name "Consol" and is available in the form of a solution for intracoronary perfusion. The solution is used for infusion into the heart arteries during surgery to stop the heart and prevent tissue damage during surgery.
As a cardioplegic, Consol has special properties that allow you to monitor and maintain the condition of the heart during surgery. It creates temporary asystole (cardiac arrest) by blocking the electrical activity of the myocardium and reducing the production of metabolic waste in the heart muscle.
The use of Consol in cardiac surgery allows surgeons to perform complex heart operations with greater safety and efficiency. It provides a stable environment for performing surgical procedures and prevents damage to heart tissue during surgery.
Consol is an example of an innovative pharmaceutical product developed and produced in Russia. It demonstrates a high level of scientific and technical achievements in the field of cardiac surgery and helps improve the quality of medical care for patients with cardiovascular diseases.
In conclusion, Consol is a drug developed for use in cardiac surgery. It is an intracoronary perfusion solution that helps control and stop the heart during open heart surgery. Thanks to its special properties, Consol contributes to the safe and effective performance of complex surgical interventions and is an important example of Russian achievements in the field of medicine.